Cargando…
Editorial: Multidisciplinary management of cancer patients with immune-related adverse events from checkpoint inhibitors
| Autores principales: | , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Frontiers Media S.A.
2023
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9850093/ https://www.ncbi.nlm.nih.gov/pubmed/36687413 http://dx.doi.org/10.3389/fmed.2022.1104382 |
| _version_ | 1784872103254687744 |
|---|---|
| author | Riveiro-Barciela, Mar Felip, Enriqueta Suarez-Almazor, María E. |
| author_facet | Riveiro-Barciela, Mar Felip, Enriqueta Suarez-Almazor, María E. |
| author_sort | Riveiro-Barciela, Mar |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-9850093 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2023 |
| publisher | Frontiers Media S.A. |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-98500932023-01-20 Editorial: Multidisciplinary management of cancer patients with immune-related adverse events from checkpoint inhibitors Riveiro-Barciela, Mar Felip, Enriqueta Suarez-Almazor, María E. Front Med (Lausanne) Medicine Frontiers Media S.A. 2023-01-05 /pmc/articles/PMC9850093/ /pubmed/36687413 http://dx.doi.org/10.3389/fmed.2022.1104382 Text en Copyright © 2023 Riveiro-Barciela, Felip and Suarez-Almazor. https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms. |
| spellingShingle | Medicine Riveiro-Barciela, Mar Felip, Enriqueta Suarez-Almazor, María E. Editorial: Multidisciplinary management of cancer patients with immune-related adverse events from checkpoint inhibitors |
| title | Editorial: Multidisciplinary management of cancer patients with immune-related adverse events from checkpoint inhibitors |
| title_full | Editorial: Multidisciplinary management of cancer patients with immune-related adverse events from checkpoint inhibitors |
| title_fullStr | Editorial: Multidisciplinary management of cancer patients with immune-related adverse events from checkpoint inhibitors |
| title_full_unstemmed | Editorial: Multidisciplinary management of cancer patients with immune-related adverse events from checkpoint inhibitors |
| title_short | Editorial: Multidisciplinary management of cancer patients with immune-related adverse events from checkpoint inhibitors |
| title_sort | editorial: multidisciplinary management of cancer patients with immune-related adverse events from checkpoint inhibitors |
| topic | Medicine |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9850093/ https://www.ncbi.nlm.nih.gov/pubmed/36687413 http://dx.doi.org/10.3389/fmed.2022.1104382 |
| work_keys_str_mv | AT riveirobarcielamar editorialmultidisciplinarymanagementofcancerpatientswithimmunerelatedadverseeventsfromcheckpointinhibitors AT felipenriqueta editorialmultidisciplinarymanagementofcancerpatientswithimmunerelatedadverseeventsfromcheckpointinhibitors AT suarezalmazormariae editorialmultidisciplinarymanagementofcancerpatientswithimmunerelatedadverseeventsfromcheckpointinhibitors |